Top Markets
Coin of the day
Bright Minds Biosciences Inc. Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG
Kedudukan dalam Saham #11319
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics... Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Harga Saham
$73.12
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$715.61M
Perubahan (1 hari)
-1.90%
Perubahan (1 tahun)
88.01%
Negara
US
Perdagangan Bright Minds Biosciences Inc. (DRUG)

Kategori

Sejarah harga saham bagi Bright Minds Biosciences Inc. (DRUG)
Harga penutupan tertinggi: $78.82 pada 2026-08-01

Harga penutupan terendah: $26.78 pada 2021-03-01
Sejarah harga saham Bright Minds Biosciences Inc. dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -9.92%
2025 104.69%
2024 2,591.40%
2023 -68.68%
2022 -73.75%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH